• The acquisition offers access to a unique solution on the market which completely cleans dental implants with peri-implantitis, setting ideal conditions for successful healing
  • The device will be accessible for the European market by the end of June 2023
  • The GalvoSurge device is compatible with most dental implant systems

 

Straumann announces the full acquisition of GalvoSurge, a Swiss medical device manufacturer in the dental field. The acquired company has specialized in implant care and maintenance solutions, offering an innovative concept to support the treatment of peri-implantitis. The device holds the CE mark and it was introduced to the market in 2020.

 

Guillaume Daniellot, Chief Executive Officer, said: “With the newly acquired GalvoSurge Dental AG, we are well-equipped to meet the increasing demand for peri-implantitis treatments and protect patients from implant loss. This preventive solution significantly improves patient satisfaction and highlights our commitment to advancing our oral care solutions and providing innovative care for patients worldwide.”

 

The GalvoSurge Dental Implant Cleaning System GS 1000 is compatible with most implant systems. The acquisition enables Straumann to serve patients globally, regardless of the implant system and deliver innovative care for peri-implantitis conditions. The GalvoSurge device is a unique solution which completely removes the biofilm matrix and decontaminates the affected implant surface, without harming healthy soft and hard tissue.

 

Peri-implantitis is a complication that must be taken seriously. It is characterized by inflammation and bone loss that can likely result in implant loss if left untreated. Therefore, clinicians are increasingly looking for solutions to treat such post-implant complications, aiming for long-lasting healthy dental implants. Eliminating biofilm is essential for the successful treatment of patients with peri-implantitis, or peri-implant mucositis. The GalvoSurge device uses an electrolytic cleaning principle for biofilm removal. This is accomplished within two minutes and without the need for conventional grinding and brushing.

 

By June 30, 2023, Straumann will begin offering the device on its eShop in Europe which ensures the supply for existing customers and enables continuation of patient treatments. The official launch is planned for the second half of 2023 under the flagship and premium brand Straumann.

 

Source: Straumann

«« NHS Plans to Improve Access to Primary Care


All Levels of the Healthcare Workforce Suffer Burnout and Work Overload »»



Latest Articles

GalvoSurge Dental AG,Straumann,dental field,medical device ,peri-implantitis Straumann announces the full acquisition of GalvoSurge, a Swiss medical device manufacturer in the dental field. The acquired company has specialized in implant care and maintenance solutions, offering an innovative concept to support the treatment of per